Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Ngā kaituhi matua: Rory Barry (Author), Gregg Murray (Author), Sally McGrath (Author), Clive Kilgallen (Author), Karen Eustace (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wiley, 2024-09-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...